174 related articles for article (PubMed ID: 20197486)
41. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
[TBL] [Abstract][Full Text] [Related]
42. In vitro P-glycoprotein interactions and steady-state pharmacokinetic interactions between tolvaptan and digoxin in healthy subjects.
Shoaf SE; Ohzone Y; Ninomiya S; Furukawa M; Bricmont P; Kashiyama E; Mallikaarjun S
J Clin Pharmacol; 2011 May; 51(5):761-9. PubMed ID: 20679500
[TBL] [Abstract][Full Text] [Related]
43. Non-obligatory role of prostaglandin D2 receptor subtype 1 in rosacea: laropiprant in comparison to a placebo did not alleviate the symptoms of erythematoelangiectaic rosacea.
Krishna R; Guo Y; Schulz V; Cord-Cruz E; Smith S; Hair S; Nahm WK; Draelos ZD
J Clin Pharmacol; 2015 Feb; 55(2):137-43. PubMed ID: 25142778
[TBL] [Abstract][Full Text] [Related]
44. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
[TBL] [Abstract][Full Text] [Related]
45. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
[TBL] [Abstract][Full Text] [Related]
46. Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarin.
Schwartz JI; Dunbar S; Yuan J; Li S; Gipson A; Rosko K; Johnson-Levonas AO; Lasseter KC; Addy C; Stoch AS; Wagner JA
Adv Ther; 2008 Nov; 25(11):1175-90. PubMed ID: 18989636
[TBL] [Abstract][Full Text] [Related]
47. Rosiglitazone does not affect the steady-state pharmacokinetics of digoxin.
Di Cicco RA; Miller AK; Patterson S; Freed MI
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1516-21. PubMed ID: 11185675
[TBL] [Abstract][Full Text] [Related]
48. The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers.
Stangier J; Su CA; Hendriks MG; van Lier JJ; Sollie FA; Oosterhuis B; Jonkman JH
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1373-9. PubMed ID: 11185636
[TBL] [Abstract][Full Text] [Related]
49. Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on the pharmacokinetics of oral contraceptives, warfarin, and digoxin in healthy participants.
Devineni D; Manitpisitkul P; Vaccaro N; Bernard A; Skee D; Mamidi RN; Tian H; Weiner S; Stieltjes H; Sha S; Rothenberg P
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):41-53. PubMed ID: 25345427
[TBL] [Abstract][Full Text] [Related]
50. The effects of tegaserod (HTF 919) on the pharmacokinetics and pharmacodynamics of digoxin in healthy subjects.
Zhou H; Horowitz A; Ledford PC; Hubert M; Appel-Dingemanse S; Osborne S; McLeod JF
J Clin Pharmacol; 2001 Oct; 41(10):1131-9. PubMed ID: 11583482
[TBL] [Abstract][Full Text] [Related]
51. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.
Hartmann M; Huber R; Bliesath H; Steinijans VW; Koch HJ; Wurst W; Kunz K
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S67-71. PubMed ID: 8793605
[TBL] [Abstract][Full Text] [Related]
52. Effects of Extended-Release Niacin and Extended-Release Niacin/Laropiprant on the Pharmacokinetics of Simvastatin in Healthy Subjects.
Lauring B; Dishy V; De Kam PJ; Crumley T; Wenning L; Liu F; Sisk C; Wagner J; Lai E
Am J Ther; 2015; 22(5):367-76. PubMed ID: 24832384
[TBL] [Abstract][Full Text] [Related]
53. Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1.
Lai E; De Lepeleire I; Crumley TM; Liu F; Wenning LA; Michiels N; Vets E; O'Neill G; Wagner JA; Gottesdiener K
Clin Pharmacol Ther; 2007 Jun; 81(6):849-57. PubMed ID: 17392721
[TBL] [Abstract][Full Text] [Related]
54. Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteers.
Schwartz JI; De Smet M; Larson PJ; Verbesselt R; Ebel DL; Lins R; Lens S; Porras AG; Gertz BJ
J Clin Pharmacol; 2001 Jan; 41(1):107-12. PubMed ID: 11144988
[TBL] [Abstract][Full Text] [Related]
55. Effect of multiple doses of fimasartan, an angiotensin II receptor antagonist, on the steady-state pharmacokinetics of digoxin in healthy volunteers.
Yi S; Kim JW; Kim TE; Kim J; Jun YK; Choi J; Yoon SH; Cho JY; Song SH; Shin SG; Jang IJ; Yu KS
Int J Clin Pharmacol Ther; 2011 May; 49(5):321-7. PubMed ID: 21543035
[TBL] [Abstract][Full Text] [Related]
56. Single- and multiple-dose pharmacokinetics, safety, and tolerability of the selective alpha7 neuronal nicotinic receptor agonist, ABT-107, in healthy human volunteers.
Othman AA; Lenz RA; Zhang J; Li J; Awni WM; Dutta S
J Clin Pharmacol; 2011 Apr; 51(4):512-26. PubMed ID: 20495134
[TBL] [Abstract][Full Text] [Related]
57. Pharmacodynamics, pharmacokinetics, and safety of AM211: a novel and potent antagonist of the prostaglandin D2 receptor type 2.
Bain G; King CD; Brittain J; Hartung JP; Dearmond I; Stearns B; Truong YP; Hutchinson JH; Evans JF; Holme K
J Clin Pharmacol; 2012 Oct; 52(10):1482-93. PubMed ID: 22110163
[TBL] [Abstract][Full Text] [Related]
58. Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers.
De Smet M; Schoors DF; De Meyer G; Verbesselt R; Goldberg MR; Fitzpatrick V; Somers G
Br J Clin Pharmacol; 1995 Dec; 40(6):571-5. PubMed ID: 8703664
[TBL] [Abstract][Full Text] [Related]
59. Lack of mutual pharmacokinetic interaction between cerivastatin, a new HMG-CoA reductase inhibitor, and digoxin in healthy normocholesterolemic volunteers.
Weber P; Lettieri JT; Kaiser L; Mazzu AL
Clin Ther; 1999 Sep; 21(9):1563-75. PubMed ID: 10509851
[TBL] [Abstract][Full Text] [Related]
60. Effect of lacosamide on the steady-state pharmacokinetics of digoxin: results from a phase I, multiple-dose, double-blind, randomised, placebo-controlled, crossover trial.
Cawello W; Mueller-Voessing C; Andreas JO
Clin Drug Investig; 2014 May; 34(5):327-34. PubMed ID: 24634110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
